Alise Reicin

CIK: 0001757533

Transaction Breakdown

Open Market Buys (P)2 (12.5%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (12.5%)

Derivative conversions

Awards (A)8 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

TECX

Tectonic Therapeutic, Inc.

DirectorOfficer

IMTX

Immatics N.V.

Director

SANA

Sana Biotechnology, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (16 total)

TECX
Tectonic Therapeutic, Inc.
Oct 26, 2026
Exercise(M)
Direct
10K shares at avg. $2.38$24K
TECX
Tectonic Therapeutic, Inc.
Sep 25, 2026
Tax Payment(F)
Direct
1.5K shares at avg. $23.67$37K
TECX
Tectonic Therapeutic, Inc.
Sep 3, 2026
Award(A)
Employee Stock Option (Right to Buy)
Direct
69.3K shares-
TECX
Tectonic Therapeutic, Inc.
Jun 20, 2026
Tax Payment(F)
Direct
924 shares at avg. $30.34$28K
IMTX
Immatics N.V.
Jun 16, 2026
Award(A)
Stock Option (Right to Buy)
Direct
48K shares-
SANA
Sana Biotechnology, Inc.
Jun 4, 2026
Award(A)
Stock Option (Right to Buy)
Direct
90K shares-
TECX
Tectonic Therapeutic, Inc.
Mar 4, 2026
Award(A)
Direct
76.5K shares-
TECX
Tectonic Therapeutic, Inc.
Feb 11, 2026
Purchase(P)
Indirect
2.5K shares at avg. $21.10$53K
TECX
Tectonic Therapeutic, Inc.
Feb 11, 2026
Purchase(P)
Direct
2.5K shares at avg. $21.10$53K
TECX
Tectonic Therapeutic, Inc.
Feb 4, 2026
Tax Payment(F)
Direct
4.1K shares at avg. $23.22$95K
TECX
Tectonic Therapeutic, Inc.
Dec 31, 2025
Exercise(M)
Direct
11K shares at avg. $2.38$26K
TECX
Tectonic Therapeutic, Inc.
Sep 25, 2025
Award(A)
Direct
14.7K shares-
TECX
Tectonic Therapeutic, Inc.
Jun 20, 2025
Tax Payment(F)
Direct
859 shares at avg. $19.81$17K
SANA
Sana Biotechnology, Inc.
Jun 5, 2025
Award(A)
Stock Option (Right to Buy)
Direct
80K shares-
TECX
Tectonic Therapeutic, Inc.
Feb 4, 2025
Award(A)
Direct
36K shares-
TECX
Tectonic Therapeutic, Inc.
Dec 4, 2024
Award(A)
Direct
11.7K shares-

		Type	Shares	Price		Ownership
Oct 26, 2026	TECX Tectonic Therapeutic, Inc.	Exercise(M)	10,000	$2.38	$23,800	Direct
Sep 25, 2026	TECX Tectonic Therapeutic, Inc.	Tax Payment(F)	1,545	$23.67	$36,570	Direct
Sep 3, 2026	TECX Tectonic Therapeutic, Inc.	Award(A) Employee Stock Option (Right to Buy)	69,250	-	-	Direct
Jun 20, 2026	TECX Tectonic Therapeutic, Inc.	Tax Payment(F)	924	$30.34	$28,034	Direct
Jun 16, 2026	IMTX Immatics N.V.	Award(A) Stock Option (Right to Buy)	48,000	-	-	Direct
Jun 4, 2026	SANA Sana Biotechnology, Inc.	Award(A) Stock Option (Right to Buy)	90,000	-	-	Direct
Mar 4, 2026	TECX Tectonic Therapeutic, Inc.	Award(A)	76,500	-	$0	Direct
Feb 11, 2026	TECX Tectonic Therapeutic, Inc.	Purchase(P)	2,500	$21.10	$52,750	Indirect
Feb 11, 2026	TECX Tectonic Therapeutic, Inc.	Purchase(P)	2,500	$21.10	$52,750	Direct
Feb 4, 2026	TECX Tectonic Therapeutic, Inc.	Tax Payment(F)	4,104	$23.22	$95,295	Direct
Dec 31, 2025	TECX Tectonic Therapeutic, Inc.	Exercise(M)	10,966	$2.38	$26,099	Direct
Sep 25, 2025	TECX Tectonic Therapeutic, Inc.	Award(A)	14,700	-	-	Direct
Jun 20, 2025	TECX Tectonic Therapeutic, Inc.	Tax Payment(F)	859	$19.81	$17,017	Direct
Jun 5, 2025	SANA Sana Biotechnology, Inc.	Award(A) Stock Option (Right to Buy)	80,000	-	-	Direct
Feb 4, 2025	TECX Tectonic Therapeutic, Inc.	Award(A)	36,047	-	-	Direct
Dec 4, 2024	TECX Tectonic Therapeutic, Inc.	Award(A)	11,717	-	$0	Direct

1-16 of 16 transactions

About REICIN ALISE

REICIN ALISE (SEC CIK 0001757533) files insider reports with the SEC as Chief Executive Officer of Tectonic Therapeutic, Inc. (TECX), Director of Immatics N.V. (IMTX) and Director of Sana Biotechnology, Inc. (SANA).

Signal8 holds 17 ownership filings by REICIN ALISE (1 Form 3, 16 Form 4), filed between Dec 6, 2024 and Oct 28, 2026. Those filings report 16 transactions, from Dec 4, 2024 to Oct 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on REICIN ALISE's filings is in WATERTOWN, MA.

Recent filings by REICIN ALISE

Oct 26, 2026: Option exercise of TECX shares (Form 4, code M).
Sep 25, 2026: Tax withholding of TECX shares (Form 4, code F).
Sep 3, 2026: Grant or award of TECX derivative securities (Form 4, code A).
Jun 20, 2026: Tax withholding of TECX shares (Form 4, code F).
Jun 16, 2026: Grant or award of IMTX derivative securities (Form 4, code A).

Other insiders filing for Tectonic Therapeutic, Inc. (TECX)

Lochner Daniel, Chief Financial Officer
McNamara Peter, Chief Scientific Officer
Ruddy Marcella K., Chief Medical Officer
Schwabish Marc, Chief Business Officer
SPRINGER TIMOTHY A, Director
Tipirneni Praveen P., Director

How to read Form 4 transaction codes